Published on: 
Supplements and Featured Publications, Definitive Management of Head Lice in the Era of Pediculicide Resistance, Volume 10, Issue 9 Suppl

The American Journal of Managed Care

This supplement to contains information on themanagement and treatment of head lice and is based on a teleconference that was held on May26, 2004. It has been peer reviewed by an expert in the field.


Barbara L. Frankowski, MD, MPH

University of Vermont

Medical Center Hospital of Vermont Campus

University Pediatrics


Ronald C. Hansen, MDProfessor, Internal Medicine (Dermatology)

University of Arizona Health Sciences Center


Miami, Florida

Sally Z. Schoessler, BSN, RN, SNT

Sherman Elementary School Teacher

Henrietta, New York


Dennis P. West, PhD, FCCP

Department of Dermatology and

Institutional Review Board

Chicago, Illinois

Elliot F. Ellis, MD

University of South Florida

Faculty Disclosure

The American Journal of Managed Care

It is the policy of to have all faculty who participate in programssponsored by corporate organizations disclose any real or apparent conflicts of interest.

The following faculty have reported relationships with the following corporate organizations:

  • Elliot F. Ellis, MDConsultant For: Odyssey Pharma TaroPharma
  • Terri L. Meinking, BAGrant/Research Support From/Consultant To:Summers LabsConsultant To: HachTech The Medical Letter XL TechnologiesGrant/Research Support From/Speaker For: TaroPharma

The following faculty report no relationships with any corporations:

  • Barbara L. Frankowski, MD, MPH

Sally Z. Schoessler, BSN, RN, SNTThe following faculty did not submit disclosure information:

  • Ronald C. Hansen, MD

Dennis P. West, PhD, FCCP

The American Journal of Managed Care

Signed disclosures are on file at the offices of , Jamesburg, New Jersey.

This program is supported by Procter & Gamble Pharmaceuticals and Aventis Pharmaceuticals.

The contents of this supplement may include information regarding the use of products that may beinconsistent with or outside the approved labeling for these products in the United States.Physicians should note that the use of these products outside current approved labeling is consideredexperimental and are advised to consult prescribing information for these products.